Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 19, 2022

Response to “About the estimation of albuminuria based on proteinuria results”

  • Guillaume Résimont EMAIL logo , Etienne Cavalier ORCID logo and Pierre Delanaye ORCID logo

Corresponding author: Guillaume Résimont, Service de Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, 4000 Liège, Belgium, Phone: +32 43667111, Fax: +32 43667205, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Remnant samples only were used in this study. No specific approval was requested to the CHU de Liège Institutional Review Board as a leaflet including the following statement is given to all admitted patients: “According to the law of the December 19, 2008, any left-over of biological material collected from patients for their standard medical management and normally destroyed when all diagnostic analysis have been performed, can be used for validation of methods. The law authorizes such use except if the patient expressed an opposition when still alive (presumed consent). Written informed consent for participation was not required for this study in accordance with the Belgian national legislation and the Institutional requirements.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Delanghe, JR, Oyaert, M, De Buyzere, ML, Speeckaert, MM. About the estimation of albuminuria based on proteinuria results. Clin Chem Lab Med 2023;61:e1–2.10.1515/cclm-2022-0820Search in Google Scholar PubMed

2. Agarwal, R, Delanaye, P. Glomerular filtration rate: when to measure and in which patients? Nephrol Dial Transplant 2019;34:2001–7. https://doi.org/10.1093/ndt/gfy363.Search in Google Scholar PubMed

3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1–150.Search in Google Scholar

4. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012;2:139–274.Search in Google Scholar

5. Résimont, G, Piéroni, L, Bigot-Corbel, E, Cavalier, E, Delanaye, P. Urinary strips for protein assays: easy to do but difficult to interpret! J Nephrol 2021;34:411–32. https://doi.org/10.1007/s40620-020-00735-y.Search in Google Scholar PubMed

Received: 2022-09-07
Accepted: 2022-09-07
Published Online: 2022-09-19
Published in Print: 2023-01-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 2.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-0879/html
Scroll to top button